Antimalarial drug resistance and the importance of drug quality monitoring.
The availability of counterfeit and poor quality drugs contribute to resistance and erroneous efficacy study results as well as directly affecting the health of individuals. This report describes the importance of drug quality monitoring as part of a comprehensive disease surveillance program.
Green
M D
MD
Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. mgreen@cdc.gov
D000962:Antimalarials / Q000627:therapeutic use*; D016903:Drug Monitoring; D004351:Drug Resistance; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D011786:Quality Control
D000962:Antimalarials